• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 17, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

A-LEAF, a full device for artificial photosynthesis

Bioengineer by Bioengineer
November 28, 2016
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
  • Project A-LEAF: "An Artificial Leaf: a photo-electro-catalytic cell from earth-abundant materials for sustainable solar production of CO2-based chemicals and fuels" receives funding from the FET Proactive 2016 call within the Horizon 2020 programme.
  • With nearly 8 million euros, A-LEAF is one of the biggest artificial photosynthesis research projects funded by the European Commission.
  • A-LEAF aims to build a photovoltaic device able to reproduce the complete process of photosynthesis to obtain clean fuels and raw materials using exclusively sunlight, water and CO2.
  • Coordinated by Prof. José Ramón Galán-Mascarós from ICIQ, the project counts with 13 partner institutions from 8 different countries. A-LEAF will start next January 2017 and will last 48 months.

The A-LEAF project seeks to respond to the world's challenge of finding new sustainable alternatives to fossil fuels. Our society has been using fossil fuels as a primary source of energy and as raw materials for synthesizing complex organic compounds with added value such as drugs, polymers or agrochemicals. The A-LEAF project aims to design, build and validate a device able to mimic this photosynthetic process as carried out by green plants. Our objective is to achieve direct transformation of water and CO2, through the action of sunlight, into oxygen and organic matter (e.g. methanol, methane). The organic products will then be used as fuels, extracting their stored energy from their recombination with oxygen back to the original feedstock (water and CO2) in an environmentally neutral closed-cycle.

Photosynthesis can be divided into several processes, including light absorption by a chromophore, charge separation and two chemical transformations: one where sunlight turns water into oxygen and releases protons and electrons; and another where these protons and electrons convert CO2 into carbohydrates, organic matter. Scientists have created artificial paltforms able to reproduce many of these sub-processes, but no integrated platform has been realized up to date.

A-LEAF is a multidisciplinary Project that brings together materials chemistry, computational chemistry, surface physics, engineering and state-of-the-art characterization techniques. The final objective of the consortium is the validation of a prototype able to transform CO2 into added-value products in a sustainable and cost-efficient way to be transferred to the European industry.

The A-LEAF project is coordinated by Prof. José Ramón Galán-Mascarós from the Institute of Chemical Research of Catalonia (ICIQ). The project's consortium also counts with two other groups from the ICIQ and 12 more partner institutions: ETH Zurich, Universiteit Leiden, IMDEA Nanociencia, EPFL, Technische Universität Wien, Universitat Jaume I de Castelló, Imperial College, Technische Universität Darmstadt, Forschungszentrum Jülich, Université de Montpellier, INSTM and COVESTRO.

###

About the Institute of Chemical Research of Catalonia (ICIQ)

ICIQ is member of the Barcelona Institute of Science and Technology and one of the most prestigious chemistry research centres worldwide. 19 research groups work on catalysis (improvement and discovery of more efficient chemical reactions, sustainable processes and drug design) and renewable energies (water splitting, photovoltaics, transformation of CO2 into fuels and materials). ICIQ is a Severo Ochoa Excellence Centre, has been awarded 14 European Research Council (ERC) grants and 9 of their researchers are ICREA professors.

Media Contact

Fernando Gomollón-Bel
[email protected]
34-977-920-200 x370
@ICIQchem

http://www.iciq.es/

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Treating Anal Lesions Lowers Invasive Cancer Risk in HIV

September 17, 2025

Exploring Mild Cognitive Impairment and Cancer in Seniors

September 17, 2025

Individual vs. Group Early Start Denver Model Effectiveness

September 17, 2025

Breakthrough Room-Temperature Terahertz Device Paves the Way for 6G Networks

September 17, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    154 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Treating Anal Lesions Lowers Invasive Cancer Risk in HIV

Exploring Mild Cognitive Impairment and Cancer in Seniors

Individual vs. Group Early Start Denver Model Effectiveness

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.